As of 2024-12-14, the Intrinsic Value of Vicore Pharma Holding AB (VICO.ST) is
-4.26 SEK. This VICO.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 7.78 SEK, the upside of Vicore Pharma Holding AB is
-154.81%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-4.26 SEK
Intrinsic Value
VICO.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-4.26 - -4.26 |
-4.26 |
-154.81% |
| P/E |
(15.62) - (26.68) |
(24.78) |
-418.5% |
| DDM - Stable |
(8.58) - (37.15) |
(22.87) |
-393.9% |
| DDM - Multi |
(8.90) - (30.40) |
(13.82) |
-277.7% |
VICO.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,825.02 |
| Beta |
-0.26 |
| Outstanding shares (mil) |
234.58 |
| Enterprise Value (mil) |
1,466.37 |
| Market risk premium |
5.10% |
| Cost of Equity |
8.51% |
| Cost of Debt |
5.00% |
| WACC |
6.75% |